报价延迟最少15分钟:2026/03/13 19:29 EDT
盘后时段
|
||||
|
108.05 
|
|
|
常规时段 (已结束)
|
|
|
|
|
||||||||||||
|
|
|
|
|
108.03
|
|
|
| 价值评估 |
|
盈利(现时/预测)
3.72/6.09
|
|
企业价值
198.74B
|
| 资产负债 |
|
每股账面净值
30.00
|
| 现金流量 |
|
现金流量率
0.05
|
| 损益表 |
|
收益
44.33B
|
|
每股收益
23.00
|
|
同行比较
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
同行比较之报价最少15分钟延迟 (夜盘时段除外)
|
业务概览
|
|||
| Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives roughly 60% of sales outside the United States. |
